Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis

BACKGROUND: No meta-analysis has holistically analysed and summarised the efficacy and safety of gemigliptin in type 2 diabetes. The meta-analysis addresses this knowledge gap. METHODS: Electronic databases were searched for randomised controlled trials (RCTs) involving diabetes patients receiving g...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Endocrinol Metab (Seoul)
Asıl Yazarlar: Dutta, Deep, Agarwal, Anshita, Maisnam, Indira, Singla, Rajiv, Khandelwal, Deepak, Sharma, Meha
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Korean Endocrine Society 2021
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090470/
https://ncbi.nlm.nih.gov/pubmed/33820392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2020.818
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller